in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza Forms Alliance and Acquires Stake in U.S. Drug Discovery Tech Firm
2:59 AM MST | March 9, 2010 | Deepti Ramesh
Lonza says it has signed an agreement with drug discovery technology company Odyssey Thera (San Ramon, CA) to make Odyssey Thera’s proprietary protein-fragment complementation assay (PCA) technology, and Odyssey Thera has granted to Lonza an option to certain exclusive global technology licenses. Lonza has made an equity investment in Odyssey Thera, and has become a minority shareholder in the company. Odyssey Thera, under the terms of the agreement, is eligible to receive technology development funding, milestones and royalties on Lonza product and service...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee